Tag: CSL Plasma
CSL boosts AU’s plasma manufacturing capability with new Fractionation Facility
Global biotech company CSL has opened a new $900 million Plasma Fractionation Facility in Victoria, bolstering the future of plasma manufacturing in Australia.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
